Download

Translating...

Content is automatically generated by Microsoft Azure Translator Text API. CGTN is not responsible for any of the translations.

Error loading player: No playable sources found
00:24

Bahrain's health regulator on December 13 announced it has approved the registration of a COVID-19 vaccine developed by the China National Pharmaceutical Group, which is known as Sinopharm.

According to Bahrain News Agency, results from phase-3 clinical trials showed an 86-percent efficacy rate, a 99-percent seroconversion rate of neutralizing antibody, and 100-percent effectiveness in preventing moderate and severe COVID-19 cases.

TOP NEWS
Boao Forum for Asia Annual Conference 2025 opens in Hainan
{"type":2,"value":"CGTN","commentator":[],"valueShow":true,"commentatorShow":false}

Politics

03:08, 27-Mar-2025

China, France oppose 'decoupling and breaking the chain'
{"type":2,"value":"CGTN","commentator":[],"valueShow":true,"commentatorShow":false}

China

11:02, 27-Mar-2025

Trump's 25% tariffs on cars spark fierce backlash from Europe
{"type":2,"value":"CGTN","commentator":[],"valueShow":true,"commentatorShow":false}

Politics

00:35, 28-Mar-2025

Search Trends